Financial Results : Al-Modawat profit soars 419% to SAR 5.5M in Q1 2025

Al-Modawat profit soars 419% to SAR 5.5M in Q1 2025

27/05/2025 Argaam Exclusive

View other reports

Al-Modawat Specialized Medical Co.’s net profit surged by 419% to SAR 5.5 million in Q1 2025 from SAR 1.1 million a year earlier.



Financials (M)

Item 3m 2024 3m 2025 Change‬
Revenues 18.56 28.68 54.5 %
Gross Income 8.55 13.58 58.9 %
Operating Income 1.42 5.89 315.5 %
Net Income 1.06 5.53 419.4 %
Average Shares 71.25 71.25 -
Earnings Per Share before unusual items (Riyals) 0.01 0.08 419.4 %
EPS (Riyal) 0.01 0.08 419.4 %

The company cited a 54.5% leap year-on-year (YoY) in revenues, driven by expansions, enhancement of service quality, and higher number of patients.

 

Total shareholders’ equity, no minority interest, reached SAR 82.65 million by the end of the current period.

View more financial results

 


Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 - - - - - -
H2 2020 - - - - - -
H1 2021 - - - - - -
H2 2021 - - - - - -
H1 2022 25.30 - 11.91 - 4.05 -
H2 2022 33.26 - 16.61 - 7.40 -
H1 2023 37.18 46.9 % 21.40 79.8 % 11.52 184.6 %
H2 2023 37.13 11.6 % 19.23 15.8 % 8.65 17.0 %
H1 2024 37.29 0.3 % 17.33 (19.0 %) 3.79 (67.1 %)
H2 2024 38.20 2.9 % 13.68 (28.8 %) 3.78 (56.3 %)
2024 75.49 1.6 % 31.01 (23.7 %) 7.56 (62.5 %)


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS(Riyal)
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 - - - - - -
H2 2020 - - - - - -
H1 2021 - - - - - -
H2 2021 - - - - - -
H1 2022 3.64 - 0.06 - 3.64 0.06
H2 2022 6.67 - 0.12 - 6.67 0.12
H1 2023 10.93 200.4 % 0.19 - 10.93 0.19
H2 2023 7.66 14.8 % 0.13 - 7.66 0.13
H1 2024 3.16 (71.1 %) 0.04 - 3.16 0.04
H2 2024 2.91 (62.0 %) 0.04 - 2.91 0.04
2024 6.07 (67.3 %) 0.09 - 6.07 0.09

Profitability

Period Gross Margin Adjusted EBITDA margin Net Margin Before Unusual Items
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 - - -
H1 2022 - - -
H2 2022 48.69 % 22.19 % 17.61 %
H1 2023 53.96 % 30.58 % 25.00 %
H2 2023 54.67 % 32.07 % 25.02 %
2023 54.68 % 32.07 % 25.02 %
H1 2024 49.12 % 22.40 % 14.54 %
H2 2024 41.08 % 17.77 % 8.05 %
2024 41.08 % 17.77 % 8.05 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Earnings Per Share before unusual items (Riyal) Book Value (BV)
H1 2015 - - - -
H2 2015 - - - -
H1 2016 - - - -
H2 2016 - - - -
H1 2017 - - - -
H2 2017 - - - -
H1 2018 - - - -
H2 2018 - - - -
H1 2019 - - - -
H2 2019 - - - -
H1 2020 - - - -
H2 2020 - - - -
H1 2021 - - - -
H2 2021 - - - -
H1 2022 57.00 - - 0.40
H2 2022 57.00 0.18 0.18 0.54
H1 2023 57.00 0.31 0.31 0.65
H2 2023 57.00 0.33 0.33 0.69
H1 2024 71.25 0.15 0.15 1.10
H2 2024 71.25 0.09 0.09 1.08

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Recurring P/E Price/book
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 - - -
H1 2022 - - -
H2 2022 - - -
H1 2023 - - -
H2 2023 - - -
H1 2024 33.35 33.35 4.60
H2 2024 66.47 66.47 5.23

Business Segments (Million)

Compared With The
Period Medical Services Pharmaceutical Products Other
H1 2022 23.69 1.61 -
H2 2022 31.82 1.44 -
H1 2023 35.50 1.67 -
H2 2023 35.40 1.73 -
H1 2024 35.27 2.01 -
H2 2024 34.88 2.55 0.78


Financial Ratios
Current
Market Cap (M Riyal) 290.70
Enterprise Value (EV) (M Riyal) 305.18
Shares Outstanding ((M)) 71.25
Book Value (BV) ( Riyal) 1.24
Par Value ( Riyal) 1.00
Recurring P/E 15.32
Price/book 3.29
EV/adj EBITDA 10.08
EV/Revenues 2.51
more

Share Price

Al-Modawat Specialized Medical Co.
4.08
0.13 3.29 %

Al-Modawat Specialized Medical Co. (ALMODAWAT)

More

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.